Skip to main content
Home
PRODUCTS
Disease areas
Evidences
SEPSIS
COVID19
ALLERGY
FERRITIN
cSOFA
SCIENTIFIC PUBLICATIONS
About Us
News
Contact
Career
Select your language
en
fr
de
it
Go
Toggle navigation
Mobile menu
Home
Products
Disease areas
Evidences
SEPSIS
COVID19
ALLERGY
FERRITIN
cSOFA
SCIENTIFIC PUBLICATIONS
About Us
Contact
News
Career
News
Media & press
All
Articles
News
Press Releases
Apply
Press Releases
Tuesday, 09 August 2022
Abionic receives IVDR certification for its predictive ultra-rapid sepsis test allowing the management of antibiotic administration
Read article
Articles
Tuesday, 31 May 2022
Practical Implementation of the Pancreatic Stone Protein Sepsis Test
Read article
News
Tuesday, 31 May 2022
Practical Implementation of the Pancreatic Stone Protein Sepsis Test
Read article
News
Thursday, 21 April 2022
Abionic is featured in the ICU Management & Practice journal ! đź“°
Check out their article on our unique sepsis detection solution & nanofluidic technology ! ⏱🩸🩺
Read article
News
Thursday, 31 March 2022
Abionic is attending the 32nd ECCMID conference in Lisbon from April 23rd to 26th!📆
Read article
News
Friday, 25 February 2022
Sparks needs new access to investors
Read article
News
Monday, 07 February 2022
Abionic at the 41st ISICEM in Brussels !
Read article
Press Releases
Tuesday, 30 November 2021
Abionic launches ultra-fast on site COVID-19 Saliva Test aimed at schools, hotels, airports and restaurants
Read article
Articles
Monday, 04 October 2021
Abionic Webinar - Advancing the Diagnosis of Sepsis in the Intensive Care Units.
Read article
Articles
Wednesday, 28 July 2021
New Study Finds Pancreatic Stone Protein to be an Early Marker for Risk Stratification in Patients with Acute Pancreatitis
Read article
Articles
Friday, 28 May 2021
New data confirms the clinical benefit of PSP for the diagnosis of severe infections in hospitalized adults
Read article
Articles
Tuesday, 20 April 2021
The Pancreatic Stone Protein (PSP) biomarker rises earlier than C-Reactive protein (CRP) and procalcitonin (PCT) in sepsis, a new study shows.
Read article
Articles
Thursday, 08 April 2021
Great symposium on the PSP Sepsis Biomarker - hosted by Abionic and Palex at the All-Virtual Galisepsis Congress
Read article
Press Releases
Monday, 30 November 2020
Abionic launches first Covid-19 severity test to triage patients quickly and accurately
Read article
Articles
Wednesday, 18 November 2020
Web Symposium hosted by Abionic - Early Identification of Sepsis
Read article
News
Wednesday, 20 May 2020
COVID-19 : LA SOLUTION DE LA SCALE-UP ABIONIC
Read article
News
Wednesday, 01 April 2020
The Battle for a Better Sepsis Test
Read article
News
Thursday, 19 March 2020
Septic shock is one of the major complications of Covid-19. Vaud-based start-up Abionic, specialized in the miniaturization of diagnostic tests, has developed a test that can detect sepsis in five minutes.
Read article
News
Wednesday, 11 March 2020
Basé au Biopôle à Lausanne, la start-up Abionic a développé un test qui permet de diagnostiquer un sepsis (choc septique) en cinq minutes à partir d’une goutte de sang. Sa détection précoce devrait permettre d’aider à prévenir ce syndrome, responsable d’environ 400 décès par an en Suisse romande.
Read article
News
Thursday, 16 January 2020
Les tests de diagnostic ultra-rapide d’Abionic bientôt dans les hôpitaux d'Europe et des Etats-Unis
Read article
Load More
Menu